Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma

Venugopal Thayanithy, Aaron L. Sarver, Reena V. Kartha, Lihua Li, Andrea Y. Angstadt, Matthew Breen, Clifford J. Steer, Jaime F. Modiano, Subbaya Subramanian

Research output: Contribution to journalArticlepeer-review

108 Scopus citations


Osteosarcoma (OS) is the common histological form of primary bone cancer and one of the leading aggressive cancers in children under age fifteen. Although several genetic predisposing conditions have been associated with OS the understanding of its molecular etiology is limited. Here, we show that microRNAs (miRNAs) at the chr.14q32 locus are significantly downregulated in osteosarcoma compared to normal bone tissues. Bioinformatic predictions identified that a subset of 14q32 miRNAs (miR-382, miR-369-3p, miR-544 and miR-134) could potentially target cMYC transcript. The physical interaction between these 14q32 miRNAs and cMYC was validated using reporter assays. Further, restoring expression of these four 14q32 miRNAs decreased cMYC levels and induced apoptosis in Saos2 cells. We also show that exogenous expression of 14q32 miRNAs in Saos2 cells significantly downregulated miR-17-92, a transcriptional target of cMYC. The pro-apoptotic effect of 14q32 miRNAs in Saos2 cells was rescued either by overexpression of cMYC cDNA without the 3'UTR or with miR-17-92 cluster. Further, array comparative genomic hybridization studies showed no DNA copy number changes at 14q32 locus in OS patient samples suggesting that downregulation of 14q32 miRNAs are not due to deletion at this locus. Together, our data support a model where the deregulation of a network involving 14q32 miRNAs, cMYC and miR-17-92 miRNAs could contribute to osteosarcoma pathogenesis.

Original languageEnglish (US)
Pages (from-to)171-181
Number of pages11
Issue number1
StatePublished - Jan 2012

Bibliographical note

Funding Information:
This study was supported by grant P30 CA077598 from the National Cancer Institute, by a Faculty Research and Development grant from the University of Minnesota Academic Health Center, by a translational research grant from the Masonic Cancer Center, University of Minnesota, by grants from the Wyckoff Rein in Sarcoma and Van Sloun Foundations, and by grants 2254 and 947 from the AKC Canine Health Foundation to JFM, MB and SS.

Copyright 2012 Elsevier B.V., All rights reserved.


  • 14q32 miRNAs
  • Bone neoplasm
  • CMYC
  • MiR-17-92
  • Osteosarcoma

Fingerprint Dive into the research topics of 'Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma'. Together they form a unique fingerprint.

Cite this